Altre lingue KORU Medical Systems, Inc.

Azioni

KRMD

US7599101026

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
2,06 ^USD	-2,83%		-7,62%	-16,09%

13/03	Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024
13/03	KORU Medical Systems, Inc. riporta i risultati degli utili per il quarto trimestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024	17/04
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review	11/04
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference	18/03
KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc	13/03
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M	13/03
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance	13/03
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024	13/03
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic	11/03
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic	11/03
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin	06/03
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin	06/03
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	21/02
KORU Medical : Investor Day 2023 Presentation	05/12
KORU Medical Systems to Participate in Piper Sandler's 35th Annual Healthcare Conference	30/11
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference	29/11
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023	28/11
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Revenue $7M, vs. Street Est of $7.9M	08/11
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System	08/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue KORU Medical Systems, Inc.

Azioni

KRMD

US7599101026

Altre lingue

Filtri